Selective protein kinase C inhibitors can either block or significantly reduce Epstein-Barr virus infectivity: inhibition of transformation and decreased 3H-thymidine (3H-TdR) incorporation in human B lymphocytes infected with B95-8 EBV, as well as a significant reduction in the induction of early antigens in Raji cells superinfected by P3HRI EBV was achieved by pre-treating the cells with the inhibitors. The inhibitors do not act by blocking binding of the virus to its cellular receptor CR 2, but rather are effective in the viral internalization process. Our results suggest that protein kinase C may be involved in the process of viral entry into cells.

Epstein-Barr virus internalization and infectivity are blocked by selective protein kinase C inhibitors / Cirone, Mara; Angeloni, Antonio; Giuseppe, Barile; Zompetta, Claudia; Marco, Venanzoni; Torrisi, Maria Rosaria; Frati, Luigi; Faggioni, Alberto. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - STAMPA. - 45:(1990), pp. 490-493. [10.1002/ijc.2910450320]

Epstein-Barr virus internalization and infectivity are blocked by selective protein kinase C inhibitors

CIRONE, Mara;ANGELONI, Antonio;ZOMPETTA, Claudia;TORRISI, Maria Rosaria;FRATI, Luigi;FAGGIONI, Alberto
1990

Abstract

Selective protein kinase C inhibitors can either block or significantly reduce Epstein-Barr virus infectivity: inhibition of transformation and decreased 3H-thymidine (3H-TdR) incorporation in human B lymphocytes infected with B95-8 EBV, as well as a significant reduction in the induction of early antigens in Raji cells superinfected by P3HRI EBV was achieved by pre-treating the cells with the inhibitors. The inhibitors do not act by blocking binding of the virus to its cellular receptor CR 2, but rather are effective in the viral internalization process. Our results suggest that protein kinase C may be involved in the process of viral entry into cells.
1990
01 Pubblicazione su rivista::01a Articolo in rivista
Epstein-Barr virus internalization and infectivity are blocked by selective protein kinase C inhibitors / Cirone, Mara; Angeloni, Antonio; Giuseppe, Barile; Zompetta, Claudia; Marco, Venanzoni; Torrisi, Maria Rosaria; Frati, Luigi; Faggioni, Alberto. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - STAMPA. - 45:(1990), pp. 490-493. [10.1002/ijc.2910450320]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/247029
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 21
social impact